Definium Therapeutics, Inc. Increase (Decrease) in Other Noncurrent Assets
Definium Therapeutics, Inc. (DFTX) reported Increase (Decrease) in Other Noncurrent Assets of $15.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-06
- Definium Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was $133.00K.
- Definium Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$118.00K, a 1280.00% decline year-over-year.
- Definium Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$17.00K, a 125.37% decline year-over-year.
- Definium Therapeutics, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$11.00K.
- Definium Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2025 was -$30.00K.
- Definium Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2024 was -$48.00K.
- Definium Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2023 was -$51.00K, a 128.33% decline from fiscal 2022.
- Definium Therapeutics, Inc. increase (decrease) in other noncurrent assets for fiscal 2022 was $180.00K.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $133.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $15.00K 10-Q · filed 2026-08-06 | -$2.00K derived: sum of 3 quarters · filed 2026-08-06 | -$13.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$118.00K 10-Q · filed 2026-05-07 | -$135.00K derived: sum of 2 quarters · filed 2026-05-07 | -$146.00K derived: sum of 3 quarters · filed 2026-05-07 | -$158.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$28.00K derived: sum of 2 quarters · filed 2026-02-26 | -$40.00K derived: sum of 3 quarters · filed 2026-08-06 | -$30.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$23.00K derived: sum of 2 quarters · filed 2026-08-06 | -$13.00K 10-Q · filed 2025-11-06 | $54.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.00K 10-Q · filed 2026-08-06 | $65.00K derived: sum of 3 quarters · filed 2026-08-06 | $40.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $10.00K 10-Q · filed 2026-05-07 | $77.00K derived: sum of 2 quarters · filed 2026-05-07 | $52.00K derived: sum of 3 quarters · filed 2026-05-07 | $28.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $42.00K derived: sum of 2 quarters · filed 2026-02-26 | $18.00K derived: sum of 3 quarters · filed 2026-02-26 | -$48.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | -$25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$49.00K derived: sum of 2 quarters · filed 2025-11-06 | -$115.00K 10-Q · filed 2025-11-06 | -$106.00K derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$24.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | -$90.00K 10-Q · filed 2025-07-31 | -$81.00K derived: sum of 3 quarters · filed 2025-07-31 | -$106.00K derived: sum of 4 quarters · filed 2025-07-31 |
| 2024-03-31 | -$66.00K 10-Q · filed 2025-05-08 | -$57.00K derived: sum of 2 quarters · filed 2025-05-08 | -$82.00K derived: sum of 3 quarters · filed 2025-05-08 | -$99.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$16.00K derived: sum of 2 quarters · filed 2025-03-06 | -$33.00K derived: sum of 3 quarters · filed 2025-03-06 | -$51.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | -$25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$42.00K derived: sum of 2 quarters · filed 2024-11-07 | -$60.00K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | -$17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$35.00K 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | -$18.00K 10-Q · filed 2024-05-08 | |||
| 2022-12-31 | $180.00K 10-K · filed 2024-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |